Regeneron Pharmaceuticals, Inc. (NASDAQ:REGN) EVP Sells $1,190,564.07 in Stock
Regeneron Pharmaceuticals, Inc. (NASDAQ:REGN – Get Free Report) EVP Marion Mccourt sold 1,137 shares of the business’s stock in a transaction on Monday, July 1st. The shares were sold at an average price of $1,047.11, for a total transaction of $1,190,564.07. Following the completion of the sale, the executive vice president now directly owns 12,931 […]
More Stories
CME Group (NASDAQ:CME) Rating Reiterated by Royal Bank of Canada
Royal Bank of Canada restated their sector perform rating on shares of CME Group (NASDAQ:CME – Free Report) in a...
Critical Comparison: Amplify Energy (NYSE:AMPY) & Sable Offshore (NYSE:SOC)
Amplify Energy (NYSE:AMPY – Get Free Report) and Sable Offshore (NYSE:SOC – Get Free Report) are both small-cap energy companies,...
Zurn Elkay Water Solutions Co. (NYSE:ZWS) Given Consensus Rating of “Hold” by Analysts
Zurn Elkay Water Solutions Co. (NYSE:ZWS – Get Free Report) has received a consensus recommendation of “Hold” from the seven...
Critical Comparison: Prothena (NASDAQ:PRTA) vs. Sonnet BioTherapeutics (NASDAQ:SONN)
Prothena (NASDAQ:PRTA – Get Free Report) and Sonnet BioTherapeutics (NASDAQ:SONN – Get Free Report) are both small-cap medical companies, but...
Reviewing Root (NASDAQ:ROOT) and Universal Insurance (NYSE:UVE)
Root (NASDAQ:ROOT – Get Free Report) and Universal Insurance (NYSE:UVE – Get Free Report) are both small-cap finance companies, but...
First National Financial Co. (TSE:FN) Receives Consensus Recommendation of “Hold” from Analysts
First National Financial Co. (TSE:FN – Get Free Report) has been given a consensus rating of “Hold” by the six...